Feng Shao

Dr. Shao is an Investigator and Deputy Director for Academic Affairs National Institute of Bilogical Sciences, Beijing, China. Recently, he showed that caspase-11, 4 and 5 are cytosolic immune receptors for LPS and activated by direct binding to its lipid A part. Like caspase-1 activation by the canonical inflammasome, caspase-11/4/5 activation induces pyroptosis, both of which are critical for antibacterial defense and development of immunological diseases. Caspase-11/4/5 and caspase-1 cleave Gasdermin D (GSDMD) to release the autoinhibition of its N-terminal domain that bears an intrinsic pore-forming activity for executing pyroptotic cell death.

Lab Information

National Institute of Biological Sciences, Beijing, China

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Cell Biology 4 Biochemical Engineering 3 Immunology 1 Pathogen-induced inflammasome activation 1 Biochemical mechanism 1

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (10)


This guy hasn’t posted anything yet.

Hot Posts for You

This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


  1. Zhou P, She Y, Dong N, et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature. 2018;561(7721):122-126.

  2. Xu Y, Zhou P, Cheng S, Lu Q, Nowak K, Hopp A, Li L, Shi X, Zhou Z, Gao W, Li D, He H, Liu X, Ding J, Hottiger M, Shao F. (2019) A Bacterial effector reveals the V-ATPase-ATG16L1 axis that initiates xenophagy, Cell, 178, 1-15.

  3. Zhou P, She Y, Dong N, Li P, He H, Borio A, Wu Q, Lu S, Ding X, Cao Y, Xu Y, Gao W, Dong M, Ding J, Wang DC, Zamyatina A, Shao F. (2018) Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose, Nature, 561, 122-126 (Published online Aug 15).

  4. Li P, Jiang W, Yu Q, Liu W, Zhou P, Li J, Xu J, Xu B, Wang F & Shao F. (2017) Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defense, Nature, 551, 378-383 (Published online Oct 11).


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud